华仁药业：2025年第三季度营业收入同比增长16.62%

Core Insights - Huaren Pharmaceutical reported a revenue of 352,374,010.10 yuan for Q3 2025, representing a year-on-year increase of 16.62% [2] - The net profit attributable to shareholders of the listed company was 17,246,910.68 yuan, showing a year-on-year decline of 22.72% [2] Financial Performance - Revenue for Q3 2025: 352.37 million yuan, up 16.62% year-on-year [2] - Net profit for Q3 2025: 17.25 million yuan, down 22.72% year-on-year [2]